Prescription Drug Affordability Board Activity through December 18, 2024

Prescription Drug Affordability Board Activity through December 18, 2024 Activities Summary Colorado: The Prescription Drug Affordability Board (PDAB) met on December 6, 2024 to hear and discuss public comment before proposing and approving revisions to policy and procedures around affordability reviews. The PDAB updated the state’s Prescription Drug Affordability Review Board and Advisory Council (PDAAC)…

[...]

JAMA Personal Drug Importation Correction

PSM’s executive director submitted the following correction to the Journal of the American Medical Association (JAMA) in December 2024: International online pharmacies are illegal, and an unacceptable cost-saving strategy  Shabbir Safdar Executive Director, The Partnership for Safe Medicines JAMA’s October 21, 2024 Special Communication, “Strategies to Help Patients Navigate High Prescription Drug Costs,” by Hussain…

[...]

Prescription Drug Affordability Board Activity through November 15, 2024

Colorado’s board reviewed proposed changes to PDAB legislation based on stakeholder testimony and board review and learned about Medicare’s Maximum Fair Price (MFP) determination. Over two meetings, Oregon’s board reviewed a draft constituent group engagement report and a UPL model that analyzed potential 2023 savings based upon MFP provided by their consultants and aggregate data collected from PBMs. The board also discussed ; policy recommendations from staff and a UPL draft report required by Senate Bill 192.

[...]